Skip to main content

Day: March 13, 2023

Foran Announces C$75 Million Brokered Private Placement

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, March 13, 2023 (GLOBE NEWSWIRE) — Foran Mining Corp. (TSXV: FOM) (OTCQX: FMCXF) (“Foran” or the “Company“) is pleased to announce that it has entered into an agreement with Eight Capital and PI Financial Corp., as co-lead agents and joint bookrunners, on behalf of a syndicate of agents (together the “Agents”) pursuant to which the Company has launched a proposed private placement (the “Offering”) for aggregate gross proceeds of up to C$75,000,540. The Offering will consist of (i) up to 13,513,600 common shares of the Company (the “Common Shares”) at an issue price of C$3.70 per Common Share, for gross proceeds of up to C$50,000,320; and (ii) up to 4,417,000 Common Shares with each such Common Share to be issued...

Continue reading

Total number of shares and voting rights at February 28, 2023

13 March 2023 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2023 2, 660, 056,599 1, 655,051 3, 122, 030,612 3, 120, 375,56102/28/2023 2, 660, 056,599 1, 281,171 3, 121, 957,722 3, 120, 676,551[1] Calculated in accordance with the...

Continue reading

AB Science reports a first complete bone marrow response in a relapsed refractory acute myeloid leukemia patient from the very low dose arm of its AB8939 Phase I/II clinical trial (AB18001)

PRESS RELEASE AB SCIENCE REPORTS A FIRST COMPLETE BONE MARROW RESPONSE IN A RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENT FROM THE VERY LOW DOSE ARM OF ITS AB8939 PHASE I/II CLINICAL TRIAL (AB18001) AB SCIENCE WILL HOST A LIVE WEBCAST ON ITS NEW MICROTUBULE PLATFORM ON THURSDAY MARCH 16, 2023, FROM 6PM TO 7PM CET Paris, 13 March, 2023, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) today announces a case report from the initial stage of its Phase I/II study (AB18001) evaluating AB8939, a microtubule destabilizer, in patients with refractory and relapsed acute myeloid leukemia (AML). The AML patient in question was in failure to prior treatment with azacitidine and presented with a MECOM gene rearrangement, which is a biomarker for resistance to standard chemotherapies that is associated with a high-risk of disease progression...

Continue reading

Groupe Casino – Nombre de droits de vote et d’actions au 28-02-2023

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 €Siège social : 1, Cours Antoine Guichard42000 Saint-Etienne554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de voteet d’actions composant le capital socialau 28 février 2023 (article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)Nombre d’actions composant le capital Nombre total de droits de vote Nombre total de droits de vote exerçables en assemblée générale108 426 230  156 326 502  156 158 881* * ** Fait le 13 mars 2023 à 17h30AttachmentCasino_Nombre de droits de vote et d’actions au 28-02-2023 – Communiqué

Continue reading

BCB Bank CEO Highlights the Bank’s Stability, Strong Capital and Diversified Sources of Funding

BAYONNE, N.J., March 13, 2023 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Bank (the “Bank”), reported the following statements made by the President and CEO of the Company and the Bank, Thomas Coughlin. “The sudden collapse of Silicon Valley Bank and Signature Bank underscores the importance of maintaining strong capitalization and diversified sources of funding as key operating measures to ensure the safety and soundness of a bank,” said Thomas Coughlin. “Unlike many other financial institutions, BCB Bank’s securities portfolio does not carry any meaningful unrealized losses that could negatively impact its capital position. BCB Bank’s philosophy is deeply rooted in maintaining robust capitalization and a diversified funding profile. Consistent profitability, evidenced by the...

Continue reading

ARGAN joins the best performing listed real estate companies by integrating the EPRA index

Information – Monday 13th March 2023 – 5.45 PM ARGAN joins the best performing listed real estate companies by integrating the EPRA index ARGAN has just received confirmation of its inclusion in the EPRA Europe index (FTSE EPRA NAREIT EUROPE) as of Monday 20 March 2023. Launched in May 2000, the EPRA index is made up of the best performing real estate stocks that are representative of the listed real estate sector in Europe. Investors rely on the expertise and professionalism of the EPRA to ensure optimal monitoring of the European market and to compare the performance of their portfolio. With approximately 500 stocks, the global index represents more than EUR 3 trillion of prime real estate worldwide. Extensive internal work was carried out to validate the 6 criteria for inclusion in the index: being listed on Euronext, having more than...

Continue reading

Disclosure of transactions in own shares from March 06th to March 10th, 2023

                         Nanterre, March 13th, 2023                      Disclosure of transactions in own shares From March 06th to March 10th, 2023 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 12, 2022 to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from March 06th to March 10th, 2023: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 6-Mar-23 FR0000125486 9 396 109,0794 XPARVINCI 6-Mar-23 FR0000125486 9 389 109,2418 CEUXVINCI 6-Mar-23 FR0000125486 5...

Continue reading

Societe Generale: shares & voting rights as of 28 February 2023

SOCIETE GENERALE: NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 28/02/2023 Regulated Information Paris, 13 March 2023 Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations.Date Number of shares composing current share capital Total number ofvoting rights28 February 2023 808,208,965Gross: 884 373 344Press contact: Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.com Societe Generale Societe Generale is one of the leading European financial services groups. Based on a diversified and integrated banking model, the Group combines financial strength and proven expertise in innovation with a strategy...

Continue reading

KBC Ancora completes share repurchase programme

Regulated information, inside information, Leuven, 13 March 2023 (17.40 hrs CET) KBC Ancora completes share repurchase programme KBC Ancora announces that the share repurchase programme, which was launched on 10 June 2022, was completed on 13 March 2023. The programme involved the repurchase of shares to an amount of EUR 50 million. A total of 1,289,470 KBC Ancora shares were repurchased, representing 1.65% of the total number of shares in issue, for a total amount of EUR 49,999,961. The average purchase price was EUR 38.78 per share. The purpose of the share repurchase programme was to reduce the number of shares with dividend entitlement. The number of KBC Ancora shares with dividend entitlement has fallen from 78,301,314 shares before the repurchase programme to 77,011,844 after completion of the programme, due to cancellation of the...

Continue reading

Nextensa : The new office building WHITE HOUSE located in the Cloche d’Or district fully let to an international company

PRESS RELEASE Brussels, 13 March 2023, 5.40 pm The new office building WHITE HOUSE located in the Cloche d’Or district fully let to an international company   Developers Nextensa and Promobe announce that they have signed a 9 year lease with a triple AAA tenant for the occupation of their WHITE HOUSE building located in the new Cloche d’Or district. The future tenant will occupy the entire WHITE HOUSE building and the ground floor and first floor in the building next door, EMERALD, for a total surface area of 8,300 sqm. The White House buildingWHITE HOUSE, designed by the architectural firm VALENTINY, will be delivered in the last quarter of 2023. The building will be leased as of the first quarter of 2024. The office building will be developed over 7 above-ground levels and a basement level that will accommodate 40 parking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.